The Globe and Mail reports in its Thursday, July 27, edition that Raymond James analyst Steve Hansen says the timing of Fairfax Financial Holdings' ($588.85) $190-million investment in AGT Food and Ingredients ($25.86) is "difficult." The Globe's David Leeder writes in the Eye On Equities column that Mr. Hansen reiterated his "market perform" rating on AGT, while trimming his share target to $32 from $35. Analysts on average target the shares at $32.67. Mr. Hansen says, "Execution will undoubtedly be vital for this plan to succeed, in our view." Mr. Hansen calls Fairfax an attractive, high-quality partner for AGT, saying it is "widely regarded as an astute long-term value investor." He adds: "Fairfax is also intimately familiar with India, the world's largest pulse consumer/importer, and a strategic market where AGT has long-term ambitions as it further advances the firm's new bulk-handling strategy. We see real value in bringing this group to the table." However, he says the timing of the deal remains an issue. The Eye column reported on April 29 that BMO Nesbitt Burns analyst Joel Jackson rated AGT "outperform." He said AGT can become "a winning small-cap stock pick again." It was then worth $31.63.